Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

DR REDDYS LABORATORIES LTD Regulatory Filings 2021

Jul 28, 2021

30528_rns_2021-07-28_f45f2b7f-4bd8-4b15-a47b-3b60a0e09548.pdf

Regulatory Filings

Open in viewer

Opens in your device viewer

•·· Dr.Reddy's ��•

Dr. Reddy's Laboratories Ltd. 8-2-337, Road No. 3, Banjara Hills, Hyderabad - 500 034, Telangana, India. CIN: L85195TG1984PLC004507

Tel :+91 40 4900 2900 Fax :+91 40 4900 2999 Email :[email protected] www.drreddys.com

July 28, 2021

To, The Secretary BSE Limited National Stock Exchange of India Ltd. New York Stock Exchange Inc. NSE IFSC Limited

Dear Sir/ Madam,

Sub: Intimation

Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, and in reference to our intimation dated July 7, 2021, please note that the Earnings Call for the quarter ended June 30, 2021, was held on July 27, 2021, at 5.30 pm IST and the audio recording of the call has been uploaded on our website. The weblink to access it is https://www.drreddys.com/investors/presentations/earnings-call/.

This is for your information and record.

Yours faithfully, For Dr. Reddy's Laboratories Limited

==> picture [145 x 71] intentionally omitted <==